Recruiting

SleepWhale Natural Sleep Drops

Sponsor:

Efforia, Inc

Code:

NCT07298161

Conditions

Sleep

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Interventions

SleepWhale Natural Sleep Drops

Study Details

Brief summary:

30-day study evaluating SleepWhale Natural Sleep Drops (Extra Strength)-formulated to support deeper sleep and better days.

Conditions

Sleep

Study ID

NCT07298161

Start date

Aug 25, 2025

Status verified date

Dec, 2025

Completion date

Aug 25, 2026

Anticipated

Primary completion date

Aug 25, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.

Exclusion Criteria:

  • Individuals with Allergies to supplement ingredients
  • Individuals on sleep Medication
  • Individuals with Gastrointestinal Issues
  • Individuals with Skin Conditions
  • Individuals Prone to Headaches
  • Individuals with Mental Health Conditions
  • Pregnant or Breastfeeding Individuals
  • Athletes and Competitive Participants
  • Individuals with Dependency Issues
  • Individuals with Dizziness or Fatigue Issues

Study Design

Enrollment

100 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Single arm where participants act as their own control

Single arm where participants act as their own control

Interventions

SleepWhale Natural Sleep Drops

Broad spectrum hemp extract: 25 mg Broad spectrum hemp extract (CBN): 1.5 mg Proprietary blend of Suntheanine (L-Theanine), GadoMag (Magnesium( Sibelius (Camomile) and M2 (Lion's Mane)

Primary outcome measure

  • PROMIS Sleep Disturbance Scale [ Time Frame: Change from baseline (Day 1-3) in PROMIS Sleep Disturbance Scale at 4 weeks (Day 28-32) ]
  • Daytime Sleepiness Perception Scale (DSPS-4) [ Time Frame: Change from baseline (Day 1-3) in DSPS-4 at 4 weeks (Day 28-32) ]
  • Fatigue Perception and Impact Survey [ Time Frame: Change from baseline (Day 1-3) in FPIS at 4 weeks (Day 28-32) ]
  • Resilience Assessment Scale [ Time Frame: Change from baseline (Day 1-3) in Resilience Assessment Scale at 4 weeks (Day 28-32) ]

Central Contacts and Locations

Central contacts

Matthew Amsden

646-679-2479help@efforia.com

Locations

Efforia

Recruiting

New York, New York, United States, 10003

Contacts

Matthew Amsden

(646) 679-2479help@efforia.com

More Information

Sponsor

Efforia, Inc

Last update posted

Dec 23, 2025

Last verified

Dec, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Efforia, Inc on 2025-12-23.